{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-039238","form_type":"8-K","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.764024+00:00","generated_at":"2026-06-02T23:13:44.240914+00:00","sec_items":["1.02"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evofem terminates merger with Aditxt due to Aditxt's failure to make Initial Parent Equity Investment","bullets":["Evofem Biosciences terminated Merger Agreement effective April 26, 2024.","Termination due to Aditxt's failure to provide the Initial Parent Equity Investment as defined in the agreement.","The Merger would have resulted in Evofem becoming a wholly owned subsidiary of Aditxt.","Aditxt had previously disclosed the Merger Agreement in December 2023.","The termination is immediate per Evofem's notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-039238","json":"https://secwatch.observer/filing/0001213900-24-039238.json","markdown":"https://secwatch.observer/filing/0001213900-24-039238.md","text":"https://secwatch.observer/filing/0001213900-24-039238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039238/0001213900-24-039238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039238/ea020519701-8k_aditxt.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:13:44.240914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1b18ed2bb93d964cad1d073388a718b729e8ad57","claim":"Aditxt, Inc. terminated Agreement and Plan of Merger with Evofem Biosciences, Inc. (effective 2024-04-26).","evidence_excerpt":"On April 26, 2024, the Company received notice from Evofem that Evofem was exercising its right to terminate the Merger Agreement effective immediately as a result of the Company’s failure to provide the Initial Parent Equity Investment (as defined in the Merger Agreement, as amended).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039238/0001213900-24-039238-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Evofem Biosciences, Inc."},{"label":"Effective","value":"2024-04-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}